Sanofi US does not review the information
contained on this website and/or database
for content, accuracy or completeness. Use
of and access to this information is subject to
the terms, limitations and conditions set by the
website and/or database producer.
This site might not comply with the regulatory requirements of US
Treatment strategy of focus on IL-4/13 in severe asthma
Takeshi Kaneko M.D.
Professor and Chairman, Department of Pulmonology,Yokohama City University Graduate School of Medicine
”Role of IL-4/13 in the pathogenesis of severe asthma”
Koichiro Matsumoto M.D.
Associate Professor, Division of Respirology, Graduate School of Medical Sciences,Kyushu University
”Update on clinical evidence for biologics in moderate to severe asthma”
Mario Castro M.D., M.P.H.
Chief, Division of Pulmonary, Critical Care and Sleep Medicine,University of Kansas School of Medicine, USA